Article Text

Download PDFPDF

Correction: Laser in glaucoma and ocular hypertension (LiGHT) Trial. A multicentre, randomised controlled trial: design and methodology

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Gazzard G, Konstantakopoulou E, Garway-Heath D, et al. Laser in Glaucoma and Ocular Hypertension (LiGHT) trial. A multicentre, randomised controlled trial: design and methodology. Br J Ophthalmol 2018;102:593–8.

There is a duplicated sentence under the paragraph ‘Defining disease progression by HRT and VF’. The second sentence is redundant and inaccurate. The correct sentence follows: ‘Possible VF Progression’ was defined as deterioration of ≥3 locations on the HFA GPA with probability of <0.05 on two consecutive tests.

Linked Articles

  • Clinical science
    Gus Gazzard Evgenia Konstantakopoulou David Garway-Heath Keith Barton Richard Wormald Stephen Morris Rachael Hunter Gary Rubin Marta Buszewicz Gareth Ambler Catey Bunce on behalf of the LiGHT Trial Study Group Gareth Ambler Keith Barton Rupert Bourne David Broadway Catey Bunce Marta Buszewicz Amanda Davis Anurag Garg David Garway-heath Gus Gazzard Rachael Hunter Yuzhen Jiang Evgenia Konstantakopoulou Sheng Lim Joanna Liput Timothy Manners Stephen Morris Neil Nathwani Gary Rubin Nicholas Strouthidis Victoria Vickerstaff Sarah Wilson Richard Wormald Haogang Zhu